CHEMBL115478 [484165]
CHEMBL115478
| SMILES | CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CCCNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@@H]2CCCN2C1=O |
| InChIKey | YOKBGCTZYPOSQM-OXWDOHASSA-N |
| Sequence | None |
| HELM | PEPTIDE1{[ac].F.[Orn]}|PEPTIDE2{P.[dCha].W.[dR]}$PEPTIDE1,PEPTIDE2,3:R2-1:R1|PEPTIDE1,PEPTIDE2,3:R3-4:R2$$$ |
Chemical Properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 9 |
| Rotatable bonds | 13 |
| Log P | 1.322 |
| Molecular weight (Da) | 895.5 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
CHEMBL115478
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0